Literature DB >> 26706277

Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.

Jin Hyang Kim1, Justine Liepkalns1, Adrian J Reber1, Xiuhua Lu1, Nedzad Music1, Joshy Jacob2, Suryaprakash Sambhara3.   

Abstract

The role of pre-existing immunity for influenza vaccine responses is of great importance for public health, and thus has been studied in various contexts, yet the impact of differential priming on vaccine responses in the midst of antigenic drift remains to be elucidated. To address this with antigenically related viruses, mice were first primed by either infection or immunization with A/Puerto Rico/8/34 (PR8) virus, then immunized with whole-inactivated A/Fort Monmouth/1/47 (FM1) virus. The ensuing vaccine responses and the protective efficacy of FM1 were superior in PR8 infection-primed mice compared to PR8 immunization-primed or unprimed mice. Increased FM1-specific Ab responses of PR8 infection-primed mice also broadened cross-reactivity against contemporary as well as antigenically more drifted strains. Further, prior infection heightened the protective efficacy of antigenically distant strains, such as A/Brisbane/59/2006 infection followed by immunization with split pandemic H1N1 vaccine (A/California/07/2009). Therefore, influenza infection is a significant priming event that intensifies future vaccine responses against drift strains. Published by Elsevier Ltd.

Entities:  

Keywords:  Antigenic drift; Infection; Influenza virus; Pandemic H1N1; Vaccine efficacy

Mesh:

Substances:

Year:  2015        PMID: 26706277      PMCID: PMC4713344          DOI: 10.1016/j.vaccine.2015.11.077

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  34 in total

1.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Authors:  Danuta M Skowronski; Travis S Hottes; Janet E McElhaney; Naveed Z Janjua; Suzana Sabaiduc; Tracy Chan; Beth Gentleman; Dale Purych; Jennifer Gardy; David M Patrick; Robert C Brunham; Gaston De Serres; Martin Petric
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

3.  Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin.

Authors:  Saleem Basha; Staci Hazenfeld; Rebecca C Brady; Ramu A Subbramanian
Journal:  Hum Immunol       Date:  2011-03-14       Impact factor: 2.850

4.  Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.

Authors:  R Bodewes; J H C M Kreijtz; M M Geelhoed-Mieras; G van Amerongen; R J Verburgh; S E van Trierum; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

5.  Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.

Authors:  Shanta M Zimmer; Corey J Crevar; Donald M Carter; James H Stark; Brendan M Giles; Richard K Zimmerman; Stephen M Ostroff; Bruce Y Lee; Donald S Burke; Ted M Ross
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

6.  Original antigenic sin responses to influenza viruses.

Authors:  Jin Hyang Kim; Ioanna Skountzou; Richard Compans; Joshy Jacob
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

7.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Authors:  Kathy Hancock; Vic Veguilla; Xiuhua Lu; Weimin Zhong; Eboneé N Butler; Hong Sun; Feng Liu; Libo Dong; Joshua R DeVos; Paul M Gargiullo; T Lynnette Brammer; Nancy J Cox; Terrence M Tumpey; Jacqueline M Katz
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

8.  Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Authors:  Rebecca J Garten; C Todd Davis; Colin A Russell; Bo Shu; Stephen Lindstrom; Amanda Balish; Wendy M Sessions; Xiyan Xu; Eugene Skepner; Varough Deyde; Margaret Okomo-Adhiambo; Larisa Gubareva; John Barnes; Catherine B Smith; Shannon L Emery; Michael J Hillman; Pierre Rivailler; James Smagala; Miranda de Graaf; David F Burke; Ron A M Fouchier; Claudia Pappas; Celia M Alpuche-Aranda; Hugo López-Gatell; Hiram Olivera; Irma López; Christopher A Myers; Dennis Faix; Patrick J Blair; Cindy Yu; Kimberly M Keene; P David Dotson; David Boxrud; Anthony R Sambol; Syed H Abid; Kirsten St George; Tammy Bannerman; Amanda L Moore; David J Stringer; Patricia Blevins; Gail J Demmler-Harrison; Michele Ginsberg; Paula Kriner; Steve Waterman; Sandra Smole; Hugo F Guevara; Edward A Belongia; Patricia A Clark; Sara T Beatrice; Ruben Donis; Jacqueline Katz; Lyn Finelli; Carolyn B Bridges; Michael Shaw; Daniel B Jernigan; Timothy M Uyeki; Derek J Smith; Alexander I Klimov; Nancy J Cox
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

9.  Fc gamma receptors and cross-presentation in dendritic cells.

Authors:  Sebastian Amigorena
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.

Authors:  Ivo M Foppa; Po-Yung Cheng; Sue B Reynolds; David K Shay; Cristina Carias; Joseph S Bresee; Inkyu K Kim; Manoj Gambhir; Alicia M Fry
Journal:  Vaccine       Date:  2015-03-23       Impact factor: 3.641

View more
  18 in total

Review 1.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

Review 2.  Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.

Authors:  Annette Fox; Kylie M Quinn; Kanta Subbarao
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

3.  Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.

Authors:  James D Allen; Hyesun Jang; Joshua DiNapoli; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season.

Authors:  Jin Hyang Kim; Margarita Mishina; Jessie R Chung; Kelly Stefano Cole; Mary Patricia Nowalk; Judith M Martin; Sarah Spencer; Brendan Flannery; Richard K Zimmerman; Suryaprakash Sambhara
Journal:  J Infect Dis       Date:  2016-08-17       Impact factor: 5.226

Review 5.  Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs.

Authors:  Santosh Dhakal; Sabra L Klein
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

6.  Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations.

Authors:  Jiwon Lee; Philipp Paparoditis; Andrew P Horton; Alexander Frühwirth; Jonathan R McDaniel; Jiwon Jung; Daniel R Boutz; Dania A Hussein; Yuri Tanno; Leontios Pappas; Gregory C Ippolito; Davide Corti; Antonio Lanzavecchia; George Georgiou
Journal:  Cell Host Microbe       Date:  2019-02-19       Impact factor: 21.023

7.  Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization.

Authors:  Emily Gage; Neal Van Hoeven; Natasha Dubois Cauwelaert; Sasha E Larsen; Jesse Erasmus; Mark T Orr; Rhea N Coler
Journal:  Eur J Immunol       Date:  2018-12-21       Impact factor: 5.532

8.  Influenza virus infection history shapes antibody responses to influenza vaccination.

Authors:  Maria Auladell; Hoang Vu Mai Phuong; Le Thi Quynh Mai; Yeu-Yang Tseng; Louise Carolan; Sam Wilks; Pham Quang Thai; David Price; Nguyen Thanh Duong; Nguyen Le Khang Hang; Le Thi Thanh; Nguyen Thi Hong Thuong; Tran Thi Kieu Huong; Nguyen Thi Ngoc Diep; Vu Thi Ngoc Bich; Arseniy Khvorov; Luca Hensen; Tran Nhu Duong; Katherine Kedzierska; Dang Duc Anh; Heiman Wertheim; Scott D Boyd; Kim L Good-Jacobson; Derek Smith; Ian Barr; Sheena Sullivan; H Rogier van Doorn; Annette Fox
Journal:  Nat Med       Date:  2022-02-17       Impact factor: 87.241

9.  Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.

Authors:  Weina Sun; Davina S Kang; Allen Zheng; Sean T H Liu; Felix Broecker; Viviana Simon; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

Review 10.  Immunity to acute virus infections with advanced age.

Authors:  Janko Nikolich-Žugich; Christine M Bradshaw; Jennifer L Uhrlaub; Makiko Watanabe
Journal:  Curr Opin Virol       Date:  2020-11-04       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.